BioHarvest Sciences completes stage 1 saffron development program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall Street indexes dip with technology earnings, rising oil in focus
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- Oil settles up more than 3% to six-week high as Mideast conflict threatens oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications
May 13, 2026 8:04 AM EDT- CDMO program advances to Stage 2 of development agreement valued at $1.125 million
-Advancement of sustainable solution for the production of saffron, one of the world's most valuable and health-promoting botanicals
- In addition to future commercial manufacturing royalties, BioHarvest also holds a 25% ownership position in Saffron Composition
Vancouver, British Columbia and Rehovot, Israel---(Newsfile Corp. - May 13, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based... More
